Clinical trial
Fluvastatin, Rosuvastatin Added to Pegylated Interferon and Ribavirin
NCT00487318 · Bader, Ted, M.D., Other · Completed
Key facts
| NCT number | NCT00487318 |
|---|---|
| Title | Fluvastatin, Rosuvastatin Added to Pegylated Interferon and Ribavirin |
| Official title | A Randomized Controlled Trial of Adding Fluvastatin to Standard Medical Treatment (SMT) and a Pilot Trial of Rosuvastatin and Other Statins With SMT, for Patients Infected With Chronic Hepatitis C Who Are Naive to Therapy. |
| Lead sponsor | Bader, Ted, M.D., Other |
| Collaborators | US Department of Veterans Affairs U.S. Fed |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C |
| Intervention type | Drug |
| Interventions | standard of care, fluvastatin |
| Enrollment | 40 |
| Start date | Jun 1, 2007 |
| Primary completion | Oct 1, 2010 |
| Completion | Oct 1, 2010 |
| First posted | Jun 18, 2007 |
| Last update posted | Aug 21, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: